When the Department of Health publishes another list of medicine price concessions, it is keeping community pharmacies open—not solving why so many generic lines ran short in the first place.
The concession tool
Concessions temporarily lift what the NHS pays when market prices spike above the drug tariff. That prevents pharmacists from dispensing at a loss when wholesalers charge more for antibiotics, hormone therapies or other lines in short supply.
The mechanism is essential for patient access this autumn, but it is by design a sticking plaster. It does not increase manufacturing capacity in India or Europe, and it does not speed inspections when quality issues shut a plant.
Staffing pressures compound the problem
NHS leaders warned this week of tight budgets and workforce gaps as hospitals prepare for colder weather. When wards are understaffed, discharge delays back up into community care, increasing demand for medicines that are already hard to source.
Pharmacies sit in the middle: they must honour prescriptions even when purchase prices jump overnight, while their own staffing costs rise. Concessions transfer some of that risk back to the taxpayer, but they do not calm anxious parents searching three towns for a paediatric antibiotic.
What policy should tackle
Ministers need a published shortage protocol that names which therapies are strategic, how much buffer stock the NHS holds, and what incentives exist for domestic fill-finish capacity. Price concessions should trigger automatic reviews of supply contracts rather than waiting for the next crisis headline.
Transparency also matters. Publishing concession lists helps pharmacists, but patients deserve clearer communication when a GP switches a script because the original molecule is unavailable.
The editorial line
InfoHandle supports any measure that keeps dispensaries solvent while shortages persist. We do not pretend that adjusting reimbursement tables is a industrial strategy. Until production and workforce plans match concession frequency, autumn ward pressures will keep feeding the very community queues concessions are meant to prevent.
Parliament’s role
MPs debating underperforming trusts this week should ask how concession spending appears in NHS England accounts and whether manufacturers are penalised for late deliveries. Without those answers, the Treasury will keep signing cheques while patients still hunt for stock.
Editors will update this file if ministers publish new data later in the day.